According to a new report, published by KBV research, The Global Thyroid Ablation Devices Market size is expected to reach $289.9 Million by 2028, rising at a market growth of 13.0% CAGR during the forecast period.
The Ambulatory Surgical Centers (ASCs) segment is showcasing a CAGR of 13.5% during (2022 - 2028). Medical facilities that function in outpatient settings and don't necessitate protracted hospital stays are known as ambulatory surgery centers. In times of injury and in cases involving accidents, these clinics offer emergency and immediate medical care. The demand for ambulatory services has increased significantly as a result of technological improvements and the use of less invasive procedures.
The Radiofrequency Ablation segment acquired maximum revenue share in the Global Thyroid Ablation Devices Market by Type in 2021 thereby, achieving a market value of $133.9 Million by 2028. This segment's expansion is fueled by the fact that RF ablation considerably reduces the need for nodule surgery and the administration of radioactive iodine (RAI). The RFA procedure is secure and less invasive. Additionally, it is a quick substitute for surgery, which typically results in a noticeable scar. Patients can resume their normal activities more quickly owing to radiofrequency ablation's shorter recovery period.
The Thyroid Nodules segment has shown the growth rate of 14.3% during (2022 - 2028). The applicability for treating thyroid nodules is expanding because thyroid ablation has the potential to both shrink thyroid nodules and restore thyroid function. Worldwide, the incidence of thyroid nodules is rising. In addition, it is projected that increasing numbers of incidences of abnormal thyroid nodule growth among people will fuel product demand in this market.
The Thermal-based Devices segment is leading the Global Thyroid Ablation Devices Market by Product in 2021 thereby, achieving a market value of $215.4 Million by 2028. A minimally invasive procedure called thermal ablation employs heat or extremely cold temperatures to kill cancerous tumor cells. Ablation is occasionally used by doctors to treat benign tumors. Using thermal ablation, a needle probe is guided into a malignant tumor with the use of ultrasonography, computed tomography, or magnetic resonance imaging (MRI).
The North America market dominated the Global Thyroid Ablation Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $108.8 Million by 2028. The Europe market is exhibiting a CAGR of 12.6% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 13.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/thyroid-ablation-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
By End-use
By Type
By Application
By Product
By Geography
Companies Profiled
Unique Offerings 
